Eugene Jiang
Officer, Director at Abvc Biopharma, Inc. (ABVC) since August 2021
Eugene Jiang has filed 1 insider report with the SEC since November 2021, as officer and director at Abvc Biopharma, Inc. (ABVC). The latest filing, on November 15, 2021, is a Form 3: Eugene Jiang became an insider at Abvc Biopharma, Inc. (ABVC).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Eugene Jiang is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer, Directorsince August 2021 | $0.94 | Nov 15, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Questions about Eugene Jiang
- What is Eugene Jiang's role at Abvc Biopharma, Inc.?
- Eugene Jiang reports to the SEC as officer and director at Abvc Biopharma, Inc. (ABVC), according to the latest filing on November 15, 2021.
- Has Eugene Jiang bought or sold stock recently?
- No open-market purchases or sales by Eugene Jiang are on file.
- How do I get alerts when Eugene Jiang files?
- Follow Eugene Jiang on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eugene Jiang (SEC CIK 0001892728). Totals count each trade once, skipping amendments whose original is on file, from Nov 15, 2021 on. View on SEC EDGAR